You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

E7438

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • +5 more
  • (no location specified)
Dec 2, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
Has Results
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021

Mesothelioma, BAP1 Loss of Function Trial in France, United Kingdom, United States (Tazemetostat)

Completed
Has Results
  • Mesothelioma
  • BAP1 Loss of Function
  • Los Angeles, California
  • +15 more
Mar 16, 2021

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Metastatic Malignant Solid

Withdrawn
  • Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Feb 6, 2020

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle-Cell Lymphoma Trial in Bebington, Liverpool (Tazemetostat

Completed
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Tazemetostat and [14C] Tazemetostat
  • Bebington, Wirral, United Kingdom
  • +1 more
Jan 8, 2020

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Post Operative Atrial Fibrillation Trial in Raleigh (CardiaMend with the Addition of Amiodarone)

Recruiting
  • Post Operative Atrial Fibrillation
  • CardiaMend with the Addition of Amiodarone
  • Raleigh, North Carolina
    WakeMed Health and Hospitals
Jan 20, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Isehara, Kanagawa, Japan
  • +1 more
Apr 6, 2022

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

Telemedicine, Critical Care, Pediatric Trial (Telemedicine Intervention)

Not yet recruiting
  • Telemedicine
  • +4 more
  • Telemedicine Intervention
  • (no location specified)
Mar 14, 2022

Brain Networks in Dystonia

Completed
  • Spasmodic Dysphonia
  • +3 more
  • MRI
  • Blood draw
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Aug 10, 2022

Epilepsy Trial in Worldwide (USL261)

Terminated
Has Results
  • Epilepsy
  • Phoenix, Arizona
  • +57 more
Jan 19, 2023

Alzheimer's Disease Trial in San Diego, Cleveland (AAV2-BDNF Gene Therapy)

Recruiting
  • Alzheimer's Disease
  • AAV2-BDNF Gene Therapy
  • San Diego, California
  • +1 more
Sep 1, 2021

Diabetic Foot Ulcer Trial in Israel (NOX-1416+SOC, Placebo+SOC)

Recruiting
  • Diabetic Foot Ulcer
  • Beersheba, Israel
  • +5 more
Aug 29, 2023

Type2 Diabetes, Osteopathy in Diseases Classified Elsewhere Trial in Central Islip, Old Westbury (OMT Protocol, OMT-Sham

Recruiting
  • Type2 Diabetes Mellitus
  • Osteopathy in Diseases Classified Elsewhere
  • OMT Protocol
  • OMT-Sham Protocol
  • Central Islip, New York
  • +1 more
Apr 25, 2022

Post-COVID-19 Syndrome, Long COVID, Vitamin D Deficiency Trial in Durango (Magnesium chloride, Vitamin D, Inert )

Not yet recruiting
  • Post-COVID-19 Syndrome
  • +3 more
  • Magnesium chloride
  • +2 more
  • Durango, Dgo, Mexico
    Biomedical Research Unit. IMSS. Durango
Dec 26, 2022

Ventricular Tachycardia, Premature Ventricular Contraction, Stroke Trial in India, United States (DOAC, Aspirin)

Completed
Has Results
  • Ventricular Tachycardia
  • +2 more
  • Kansas City, Kansas
  • +4 more
Aug 30, 2021

Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

Active, not recruiting
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +584 more
Jan 28, 2023